NCT04056559

Brief Summary

The aim of this study is to the validate adaptable mouthguards prototypes, patented by Bordeaux University and Bordeaux University Hospital.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2011

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 9, 2011

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 29, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 29, 2012

Completed
7.1 years until next milestone

First Submitted

Initial submission to the registry

August 13, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 14, 2019

Completed
Last Updated

August 14, 2019

Status Verified

August 1, 2019

Enrollment Period

10 months

First QC Date

August 13, 2019

Last Update Submit

August 13, 2019

Conditions

Keywords

PrototypeAdaptable mouthguards

Outcome Measures

Primary Outcomes (7)

  • Impact on ventilatory flow rate by minute

    Average of measured values in one minute, compared to maximum aerobic reference speed of the subject Modification of the ventilatory flow rate by min

    At Week 51

  • Impact on O2 consumption

    Average of measured values in one minute, compared to reference of the subject

    At Week 51

  • Impact on respiratory rate

    Average of measured values in one minute, compared to reference of the subject

    At Week 51

  • Impact on current volume

    Average of measured values in one minute, compared to reference of the subject

    At Week 51

  • Impact on CO2 production

    Average of measured values in one minute, compared to reference of the subject

    At Week 51

  • Impact on comfort according an analogical visual scale for 11 criteria

    According an analogical visual scale (from 0 to 10) for 11 criteria (retention, muco-gingival appearance, mouth opening height, volume of mouthguards, nausea, phonation, open mouth ventilation, tight jaw ventilation, salivation, masticatory muscles, temporomandibular joint)

    At Week 51

  • Impact on electromyographic recording

    The electromyographic activity will be amplified and filtered (bandwidth 10-1000 Hz). The signals will be digitized using a CED 1401 interface coupled to a microcomputer that is controlled by the "SPIKE2" software. The digitization frequency will be 2,000 Hz. The software "SPIKE2" will then calculate what is called "integrated electromyogram": the electromyographic signals will be rectified and filtered with a moving average having a period of 0,2 seconds.

    At Week 52

Study Arms (1)

SIngle arm

EXPERIMENTAL

The research is based on a population of men and women practicing a sport at risk of oral trauma.

Device: Adaptable mouthguards

Interventions

Validate a prototype of Adaptable Intra-Oral Protections patented by Bordeaux University and Bordeaux University Hospital according to 3 levels (ventilation, comfort, cervical muscle activity).

SIngle arm

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Subject aged 18 to 35,
  • Subject affiliated to a social security,
  • Subject who has signed the free and informed consent form.

You may not qualify if:

  • Subject with a pathology incompatible with the performance of the test, namely: Recent infarction,Threat syndrome, blood pressure resting\> 200/120 mmHg, uncompensated cardiac insufficiency, atrioventricular block 3rd degree acquired, Myocarditis, Pericarditis, Endocarditis, Aortic Dissection, Intracardiac Tumor or Thrombus, Deep Vein Thrombosis, Pulmonary Embolism,
  • Subject under B-mimetic drug treatment,
  • Subject under safeguard of justice,
  • Subject participating in another search,
  • Subject during pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Oral Manifestations

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Philippe POISSON, Dr

    University Hospital, Bordeaux

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Model Details: Single
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 13, 2019

First Posted

August 14, 2019

Study Start

September 9, 2011

Primary Completion

June 29, 2012

Study Completion

June 29, 2012

Last Updated

August 14, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share